Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
4.
Orv Hetil ; 147(31): 1455-8, 2006 Aug 06.
Artículo en Húngaro | MEDLINE | ID: mdl-16981418

RESUMEN

Adrenal abscess is a rare disease in the neonatal period. The classical symptoms are abdominal mass, anaemia and prolonged jaundice which are associated with fever, vomiting and feeding difficulties. The authors present the histories of two mature, male newborns with adrenal hemorrhage, where the size of the masses increased progressively and finally adrenal abscesses were developed. The first case showed the classical symptoms of adrenal abscess, however, the antibiotic treatment led to complete remission of the symptoms and laboratory infectious markers, therefore the baby was discharged. In a few day later he became septic and was admitted again. This time he was operated on and a large abscess was evacuated, which contained about 60 ml of pus. After this intervention multi-organ failure developed, but due to the intensive therapy the baby recovered. In the second newborn the increasing adrenal hemorrhage was accompanied by elevated infectious markers despite of the different antibiotic treatments, however, he showed no clinical signs of infection. Because of the discrepancies between the clinical and laboratory findings and also the imaging studies the possibility of neuroblastoma has also arisen. Urinary vanillylmandelic acid excretion was normal, but elevated neuron-specific enolase levels were measured. Surgical exploration was performed, pus was drained from the mass and anaerobic Bacteroides fragilis was cultured, therefore metronidazole therapy was started. After that the baby fully recovered.


Asunto(s)
Absceso/diagnóstico , Enfermedades de las Glándulas Suprarrenales/diagnóstico , Absceso/complicaciones , Absceso/terapia , Enfermedades de las Glándulas Suprarrenales/complicaciones , Enfermedades de las Glándulas Suprarrenales/terapia , Antiinfecciosos/uso terapéutico , Bacteroides fragilis/aislamiento & purificación , Diagnóstico Diferencial , Humanos , Recién Nacido , Masculino , Metronidazol/uso terapéutico , Insuficiencia Multiorgánica/etiología , Resultado del Tratamiento
5.
J Lipid Res ; 47(2): 404-11, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16299352

RESUMEN

Most lipid emulsions for parenteral feeding of premature infants are based on long-chain triacylglycerols (LCTs), but inclusion of medium-chain triacylglycerols (MCTs) might provide a more readily oxidizable energy source. The influence of these emulsions on fatty acid composition and metabolism was studied in 12 premature neonates, who were randomly assigned to an LCT emulsion (control) or an emulsion with a mixture of MCT and LCT (1:1). On study day 7, all infants received [13C]linoleic (LA) and [13C]alpha-linolenic acid (ALA) tracers orally. Plasma phospholipid (PL) and triacylglycerol (TG) fatty acid composition and 13C enrichments of plasma PL fatty acids were determined on day 8. After 8 days of lipid infusion, plasma TGs in the MCT/LCT group had higher contents of C8:0 (0.50 +/- 0.60% vs. 0.10 +/- 0.12%; means +/- SD) and C10:0 (0.66 +/- 0.51% vs. 0.15 +/- 0.17%) than controls. LA content of plasma PLs was slightly lower in the MCT/LCT group (16.47 +/- 1.16% vs. 18.57 +/- 2.09%), whereas long-chain polyunsaturated derivatives (LC-PUFAs) of LA and ALA tended to be higher. The tracer distributions between precursors and products (LC-PUFAs) were not significantly different between groups. Both lipid emulsions achieve similar plasma essential fatty acid (EFA) contents and similar proportional conversion of EFAs to LC-PUFAs. The MCT/LCT emulsion seems to protect EFAs and LC-PUFAs from beta-oxidation.


Asunto(s)
Emulsiones Grasas Intravenosas/farmacología , Ácidos Grasos/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Triglicéridos/metabolismo , Ácido 3-Hidroxibutírico/sangre , Ácido 3-Hidroxibutírico/metabolismo , Peso Corporal , Isótopos de Carbono , Carnitina/análogos & derivados , Carnitina/sangre , Carnitina/metabolismo , Colesterol/sangre , Colesterol/metabolismo , Método Doble Ciego , Emulsiones Grasas Intravenosas/administración & dosificación , Ácidos Grasos/análisis , Ácidos Grasos/sangre , Ácidos Grasos Esenciales/análisis , Ácidos Grasos Esenciales/sangre , Ácidos Grasos Esenciales/metabolismo , Ácidos Grasos no Esterificados/sangre , Ácidos Grasos no Esterificados/metabolismo , Ácidos Grasos Insaturados/análisis , Ácidos Grasos Insaturados/sangre , Ácidos Grasos Insaturados/metabolismo , Femenino , Humanos , Recién Nacido , Recien Nacido Prematuro , Masculino , Fosfolípidos/sangre , Fosfolípidos/química , Fosfolípidos/metabolismo , Triglicéridos/sangre , Triglicéridos/química , Ácido alfa-Linolénico/administración & dosificación , Ácido alfa-Linolénico/farmacología , alfa-Tocoferol/sangre , alfa-Tocoferol/metabolismo , gamma-Tocoferol/sangre , gamma-Tocoferol/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA